Fengshuo Lan is an Oncology physician affiliated with Stony Brook University Hospital. OpenAlex indexes 19 publications with 1,381 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Stony Brook University Cancer Ctr
3 Edmund D. Pellegrino Road
Stony Brook, NY 117940001
Telephone
631-638-1000Registry record last updated 28 Jun 2013.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20241 payment
- SOBI, INCProgram year20242 payments
- Kyowa Kirin, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
23.2%Factor Xa inhibitor14.2%Eliquis100%Part D≥20 patientsVitamin K antagonist4.5%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
22.7%Antimetabolite8.1%Hydroxyurea100%Part D<11 patientsCalcineurin inhibitor4%Cyclosporine100%Part D<11 patients+ 3 more classes in this area
Anti-infectives
18.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.5%Valacyclovir100%Part D<11 patientsAzole Antifungal4.3%Voriconazole100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predictivity of coagulation markers in diagnosing acute promyelocytic leukemia.
Journal of Clinical Oncology
2026 - High Incidence of Gvhd after Tapering Off Immunosuppression to Increase Donor T cell Chimerism
Biology of Blood and Marrow Transplantation
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Samuel Ryu, MD
Stony Brook University Hospital
Shenhong Wu, MD
Stony Brook University Hospital
Wadie Bahou, MD
Stony Brook University Hospital
Roger Keresztes, MD
Stony Brook University Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”